The assessment of pulmonary diffusing capacity in diabetes mellitus with regard to microalbuminuria

Internal Medicine

Volumn 48, Issue 22, 2009, Pages 1939-1943

  Saler, Tayyibe ^a   Cakmak, Gulfidan ^a   Saglam, Zuhal Aydan ^a   Ataoglu, Esra ^a   Erdem, Tijen Yesim ^a   Yenigun, Mustafa ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diabetes mellitus; Microalbuminuria; Pulmonary diffusing capacity

Indexed keywords

ALBUMIN; CARBON MONOXIDE;

ADULT; AGE; ARTICLE; BODY MASS; BREATH ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LUNG DIFFUSION CAPACITY; LUNG DISEASE; LUNG GAS EXCHANGE; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; SEX DIFFERENCE; SPIROMETRY; URINARY EXCRETION; VASCULAR DISEASE;

ADULT; ALBUMINURIA; DIABETES MELLITUS; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY;

EID: 71049192414     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.2417     Document Type: Article

References (27)

1. Innocenti F, Fabbri A, Anichini R. Indications of reduced pulmonary function in type 1 diabetes mellitus. Diabetes Res Clin Pract 25: 161-168, 1994.
2. Weir DC, Jennings PE, Hendy MS, et al. Transfer factor for carbon monoxide in patients with diabetes with and without microangiopathy. Thorax 43: 725-726, 1988. (Pubitemid 18223689)
3. Chance WW, Rhee C, Yilmaz C, et al. Diminished alveolar microvascular reserves in type 2 diabetes reflect systemic microangiopathy. Diabetes Care 31: 1596-1601, 2008.
4. Weynand B, Jonckheere A, Frans A, et al. Diabetes mellitus induces a thickening of the pulmonary basal lamina. Respiration 66: 14-19, 1999. (Pubitemid 29089987)
5. Vracko R, Thorning D, Huang TW. Basal lamina of alveolar epithelial and capillaries. Quantitative changes with aging and diabetes mellitus. Am Rev Respir Dis 120: 973-983, 1979.
6. Sandler M. Is the lung a "target organ" in diabetes mellitus? Arch Intern Med 150: 1385-1388, 1990.
7. Perticone F, Maio R, Tripepi G, et al. Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension. J Nephrol 12: S56-S62, 2007. (Pubitemid 351266139)
8. Stehouwer CD, Smulders YM. Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms. J Am Soc Nephrol 17: 2106-2111, 2006. (Pubitemid 44141899)
9. Jensen JS, Feldt-Rasmussen B, Strandgaard S, et al. Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35: 898-903, 2000. (Pubitemid 30303947)
10. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, et al. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arteroscler Thromb Vasc Biol 19: 1992-1997, 1999.
11. Amin R, Turner C, van Aken S, et al. The relationship between microalbuminuria and glomerular filtration rate in young Type 1 diabetic subjects: the Oxford regional prospective study. Kidney Int 68: 1740-1749, 2005. (Pubitemid 43169918)
12. Fuso L, Cotroneo P, Basso S, et al. Postural variations of pulmonary diffusing capacity in insulin dependent diabetes mellitus. Chest 110: 1009-1013, 1996. (Pubitemid 26347619)
13. American Thoracic Society. Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 152: 1107-1136, 1995.
14. American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor): recommendations for a standard technique. 1995 update. Am J Respir Crit Care Med 152: 2185-2198, 1995.
15. Quanjer PH. Standardized lung function testing. Report Working Party. Standardization of lung function tests. European community for coal and steel. Bull Eur Physiopathol Respir 19: S1-S82, 1983.
16. Aorosio E, Minuz P, Prior M. Endothelial function and the microcirculation in diabetes mellitus. Ann Ital Med Int 14: 106-113, 1999. (Pubitemid 29290901)
17. Marvisi M, Bartolini L, Borello P, et al. Pulmonary function in non-insulin dependent diabetes mellitus. Respiration 68: 268-272, 2001. (Pubitemid 32588901)
18. Bell D, Collier A, Matthews DM, et al. Are reduced lung volumes in IDDM due to defect in connective tissue? Diabetes 37: 829-831, 1988.
19. Assanuma Y, Fujiya S, Ide H, et al. Characteristics of pulmonary function in patients with diabetes mellitus. Diabetes Res Clin Pract 1: 95-101, 1985. (Pubitemid 17034154)
20. Ofulue AF, Thurlbeck WM. Experimental diabetes and the lung. II. In vivo connective tissue metabolism. Am Rev Respir Dis 138: 284-289, 1988.
21. Ofulue AF, Kida K, Thurlbeck WM. Experimental diabetes and the lung. Am Rev Respir Dis 137: 162-166, 1988.
22. LjubiS, Metelko Z, Car N, et al. Reduction of diffusion capacity for carbon monoxide in diabetic patients. Chest 114: 1033-1035, 1998. (Pubitemid 28495898)
23. Guvener N, Tutuncu NB, Akcay S, et al. Alveolar gas exchange in patients with type 2 diabetes mellitus. Endocr J 50: 663-667, 2003. (Pubitemid 38139948)
24. Schnack C, Festa A, Schwarzmaier-D'Assié A, Haber P, Schernthaner G. Pulmonary dysfunction in type 1 diabetes in relation to metabolic long-term control and to incipient diabetic nephropathy. Nephron 74: 395-400, 1996. (Pubitemid 26326716)
25. Mori H, Okubo M, Okamura M, et al. Abnormalities of pulmonary function in patients with non-insulin-dependent diabetes mellitus. Intern Med 31: 189-193, 1992.
26. Soedamah-Muthu SS, Visseren FL, Algra A, et al; SMART Study Group. The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study. Diabet Med 25: 51-57, 2008.
27. Bøg-Hansen E, Larsson CA, Gullberg B, et al. Predictors of acute myocardial infarction mortality in hypertensive patients treated in primary care: a population-based follow-up study in the Skaraborg Project. Scand J Prim Health Care 25: 237-243, 2007. (Pubitemid 350179035)